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Chloroquine resistant falciparum malaria has rapidly 
spread over central and west Africa (WERNSDORFER & 
PAYNE, 1991). In southern Cameroon chloroquine resist- 
ance was first reported by SANSONNETTI et al. (1985). 
We measured chloroquine sensitivity in vivo of Plasmo- 
dium falciparum in May 1989 and 1991 in schoolchildren 
in the town of Edea, southern Cameroon, and observed 
considerable increase over 2 years (GAZIN et al., 1990; 
MULDER et al., 1992). Parallel studies in vivo in 
Table 1. Characteristics of schoolchildren in Edea, Came- 
roon, in May of 1989, 1991 and 1993 before antimalarial 
treatment 
1989 1991 1993 
Number 190 191 197 
Aee (years) 9.0 8.9 8.4 
tight (kg) 25.9 26.6 25.1 
deo/n’l 45.0 51.4 sn.3 
Wt-_--. 
Sex (mc.. . .
Parasite rat<(%)” 64;5 (63.1) 67:i (63.3) 56:g (50.8) 
GMPDb 447 
Spleen rate 27.0 27.0 23.9 
SDleen Size‘ 1.46 (zkO.66) 1.70 (+@74) 1.79 (F0.62) 
501 489 
“Numbers in parentheses are the percentages of P. falciparuaz 
infections. 
bGeometric mean parasite density (parasitized red blood cells/ 
mm3 of blood) on day O. 
‘Average enlarged spleen according to Hacket (see MANSON- 
BAHR & BELL, 1987); standard deviations are given in 
parentheses). 
Yaoundé, the capital of Cameroon, suggested that chlo- 
roquine resistance was stabilizing (LOUIS et al., 1992a). 
To monitor the evolution of resistance in vivo of P.  falci- 
parum in our study population we repeated the test in the 
same school classes in May 1993. 
All pupils present on the first day of the study (day O) 
were given 25 mg!kg chloroquine base orally over 3 d 
under supervision. Spleen rate, weight and parasite den- 
sity were assessed. Parasite densities were also assessed 
on days 3 to 7. Subjects with a parasitaemia on day O ex- 
clusively of P.  falciparum, with parasite counts of at least 
500 trophozoites/mm3 and who had taken their 3 d treat- 
ment on days O, 1 and 2, were included in the sensitivity 
test. 
Over the 3 studies, the groups did not differ signifi- 
cantly in number, age, weight, sex, spleen rate or para- 
site density on day O (Table 1). Sixty-eight children met 
the enrolment criteria in 1989,52 in 1 W a n d  51 in 1993. 
Their parasitological results are given in Table 2. 
Between 1989 and 1991 parasite resistance in vivo had 
increased significantly from 17.5% to 44%. In 1993 an 
overall resistance percentage of 31.5 was observed. Two 
subjects (2.9%) showed RI11 resistance (no reduction in 
parasitaemia) in 1989; in 1991 this was so for 4 (7-7%), 
Table 2. Prevalence and intensity of Plasmodium para- 
sitaemia in schoolchildren in Edea, Cameroon, who were 
included in the chloroquine resistance test in vivo 
1989 1991 1993 
No. of children (day O) 68 52 51 
Parasite rate (%) 
Day 3 24 38 51 
Dav 7 17.5 44 31.5 
14i 108 
while in 1993 only 2 cases (3.9%) of RI1 resistance were 
observed. 
We conclude that, after rapid emergence, chloroquine 
resistance has stabilized or may even be regressing in this 
region, as was also found for other central and west Afri- 
can countries (BASCO et al., 1993). No explanation has 
been given for this phenomenon, but changing consump- 
tion towards other antimalarial drugs might play a role, 
In 1991 one-third of the patients presenting at a dispen- 
sary in Edea stated that they had taken quinine at home, 
often at insufficient doses (B. Mulder, unpublished 
data). Our findings indicate that chloroquine remains 
useful for home medication, while for first line treatment 
amodiaquine at a dose of 35 mg/kg over 3 d was found to 
be efficient (LOUIS et al., 1992b). Although encouraging, 
stabilization of resistance in vivo might be temporary, 
emphasizing the need for constant monitoring in central 
African countries in order to adapt therapeutic schemes. 
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